Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

RAPT Therapeutics (RAPT) Consolidated Net Income: 2018-2023

Historic Consolidated Net Income for Therapeutics (RAPT) over the last 6 years, with Dec 2023 value amounting to -$127.1 million.

  • Therapeutics' Consolidated Net Income fell 35.96% to -$33.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$127.1 million, marking a year-over-year decrease of 48.10%. This contributed to the annual value of -$127.1 million for FY2023, which is 48.10% down from last year.
  • According to the latest figures from FY2023, Therapeutics' Consolidated Net Income is -$127.1 million, which was down 48.10% from -$85.8 million recorded in FY2022.
  • In the past 5 years, Therapeutics' Consolidated Net Income registered a high of -$43.0 million during FY2019, and its lowest value of -$127.1 million during FY2023.
  • Its 3-year average for Consolidated Net Income is -$94.0 million, with a median of -$85.8 million in 2022.
  • Data for Therapeutics' Consolidated Net Income shows a maximum YoY tumbled of 48.10% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Therapeutics' Consolidated Net Income stood at -$43.0 million in 2019, then fell by 23.01% to -$52.9 million in 2020, then crashed by 30.84% to -$69.2 million in 2021, then decreased by 23.97% to -$85.8 million in 2022, then plummeted by 48.10% to -$127.1 million in 2023.